U.S. Markets close in 5 hrs 54 mins

New Research: Key Drivers of Growth for ICU Medical, A. Schulman, Verso, Eli Lilly, Spectrum Pharmaceuticals, and Intuit — Factors of Influence, Major Initiatives and Sustained Production

NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ICU Medical, Inc. (ICUI), A. Schulman, Inc. (SHLM), Verso Corporation (VRS), Eli Lilly and Company (LLY), Spectrum Pharmaceuticals, Inc. (SPPI), and Intuit Inc. (INTU), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ICUI DOWNLOAD: http://Fundamental-Markets.com/register/?so=ICUI
SHLM DOWNLOAD: http://Fundamental-Markets.com/register/?so=SHLM
VRS DOWNLOAD: http://Fundamental-Markets.com/register/?so=VRS
LLY DOWNLOAD: http://Fundamental-Markets.com/register/?so=LLY
SPPI DOWNLOAD: http://Fundamental-Markets.com/register/?so=SPPI
INTU DOWNLOAD: http://Fundamental-Markets.com/register/?so=INTU

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine ICU Medical, Inc. (ICUI), A. Schulman, Inc. (SHLM), Verso Corporation (VRS), Eli Lilly and Company (LLY), Spectrum Pharmaceuticals, Inc. (SPPI), and Intuit Inc. (INTU) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed July 25th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

ICU MEDICAL, INC. (ICUI) REPORT OVERVIEW

ICU Medical's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, ICU Medical reported revenue of $372.03MM vs $247.74MM (up 50.17%) and basic earnings per share $0.24 vs $3.03 (down 92.08%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, ICU Medical reported revenue of $1,292.61MM vs $379.37MM (up 240.72%) and basic earnings per share $3.50 vs $3.90 (down 10.26%). ICU Medical is expected to report earnings on August 9th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.52. The estimated EPS forecast for the next fiscal year is $8.61 and is expected to report on March 7th, 2019.

To read the full ICU Medical, Inc. (ICUI) report, download it here: http://Fundamental-Markets.com/register/?so=ICUI

-----------------------------------------

A. SCHULMAN, INC. (SHLM) REPORT OVERVIEW

A. Schulman's Recent Financial Performance

For the three months ended May 31st, 2018 vs May 31st, 2017, A. Schulman reported revenue of $722.24MM vs $645.80MM (up 11.84%) and basic earnings per share $0.11 vs $0.47 (down 76.60%). For the twelve months ended August 31st, 2017 vs August 31st, 2016, A. Schulman reported revenue of $2,461.12MM vs $2,496.01MM (down 1.40%) and basic earnings per share $0.87 vs -$12.44. A. Schulman is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending May 31st, 2018. The reported EPS for the same quarter last year was $0.63. The estimated EPS forecast for the next fiscal year is $2.67 and is expected to report on October 24th, 2018.

To read the full A. Schulman, Inc. (SHLM) report, download it here: http://Fundamental-Markets.com/register/?so=SHLM

-----------------------------------------

VERSO CORPORATION (VRS) REPORT OVERVIEW

Verso's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Verso reported revenue of $639.00MM vs $616.00MM (up 3.73%) and basic earnings per share -$0.06 vs -$0.61. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Verso reported revenue of $2,461.00MM vs $2,641.00MM (down 6.82%) and basic earnings per share -$0.87 vs $33.32. Verso is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$1.42. The estimated EPS forecast for the next fiscal year is $1.99 and is expected to report on March 14th, 2019.

To read the full Verso Corporation (VRS) report, download it here: http://Fundamental-Markets.com/register/?so=VRS

-----------------------------------------

ELI LILLY AND COMPANY (LLY) REPORT OVERVIEW

Eli Lilly's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Eli Lilly reported revenue of $5,700.00MM vs $5,228.30MM (up 9.02%) and basic earnings per share $1.16 vs -$0.10. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Eli Lilly reported revenue of $22,871.30MM vs $21,222.10MM (up 7.77%) and basic earnings per share -$0.19 vs $2.59. Eli Lilly is expected to report earnings on October 23rd, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $1.05. The estimated EPS forecast for the next fiscal year is $5.59 and is expected to report on January 30th, 2019.

To read the full Eli Lilly and Company (LLY) report, download it here: http://Fundamental-Markets.com/register/?so=LLY

-----------------------------------------

SPECTRUM PHARMACEUTICALS, INC. (SPPI) REPORT OVERVIEW

Spectrum Pharmaceuticals' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Spectrum Pharmaceuticals reported revenue of $30.50MM vs $29.10MM (up 4.79%) and basic earnings per share -$0.16 vs -$0.30. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Spectrum Pharmaceuticals reported revenue of $128.37MM vs $146.44MM (down 12.34%) and basic earnings per share -$1.07 vs -$0.96. Spectrum Pharmaceuticals is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.26. The estimated EPS forecast for the next fiscal year is -$0.75 and is expected to report on March 5th, 2019.

To read the full Spectrum Pharmaceuticals, Inc. (SPPI) report, download it here: http://Fundamental-Markets.com/register/?so=SPPI

-----------------------------------------

INTUIT INC. (INTU) REPORT OVERVIEW

Intuit's Recent Financial Performance

For the three months ended April 30th, 2018 vs April 30th, 2017, Intuit reported revenue of $2,925.00MM vs $2,541.00MM (up 15.11%) and basic earnings per share $4.68 vs $3.76 (up 24.47%). For the twelve months ended July 31st, 2017 vs July 31st, 2016, Intuit reported revenue of $5,177.00MM vs $4,694.00MM (up 10.29%) and basic earnings per share $3.78 vs $3.73 (up 1.34%). Intuit is expected to report earnings on August 28th, 2018. The report will be for the fiscal period ending July 31st, 2018. The reported EPS for the same quarter last year was $0.10. The estimated EPS forecast for the next fiscal year is $5.26 and is expected to report on August 28th, 2018.

To read the full Intuit Inc. (INTU) report, download it here: http://Fundamental-Markets.com/register/?so=INTU

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.


  • Dow off more than 300 points on earnings, China selloff
    News
    MarketWatch

    Dow off more than 300 points on earnings, China selloff

    It was a punishing start for stocks Tuesday as investors reacted negatively to earnings from some blue chips and a two-day rebound for China’s stock market fell prey to renewed selling, reviving questions about global economic growth prospects. The Dow Jones Industrial Average (DJIA) fell more than 400 points after the opening bell and remained down 328 points, or 1.3%, at 24,982. The S&P 500 (SPX) fell 42 points, or 1.5%, to 2,714, while the Nasdaq Composite Index (COMP) slid 134 points, or 1.8%, to 7,334.

  • Suze Orman missed the point of retirement, and that’s why she went back to work
    News
    MarketWatch

    Suze Orman missed the point of retirement, and that’s why she went back to work

    Suze Orman did a smackdown of the FIRE (Financial Independence/Retire Early) movement on Paula Pant’s podcast. Coach Carson posted a balanced, informative response, appreciating Suze’s admonition to be sure you have enough for a risk-free retirement. Suze enumerated a string “what can go wrong” scenarios as evidence that early retirement (on less than $10 million) leaves you vulnerable when life hands you lemons — a whole tree of lemons.

  • Is a Surprise Coming for Advanced Micro Devices (AMD) This Earnings Season?
    Business
    Zacks

    Is a Surprise Coming for Advanced Micro Devices (AMD) This Earnings Season?

    Investors are always looking for stocks that are poised to beat at earnings season and Advanced Micro Devices, Inc. AMD may be one such company. In fact, the Most Accurate Estimate for the current quarter is currently higher than the broader Zacks Consensus Estimate of 13 cents per share. This suggests that analysts have very recently bumped up their estimates for AMD, giving the stock a Zacks Earnings ESP of +2.63% heading into earnings season.

  • How Energy Transfer Stock Has Fared
    Finance
    Market Realist

    How Energy Transfer Stock Has Fared

    How Energy Transfer Stock Has Fared Energy Transfer completes simplification Energy Transfer Equity and Energy Transfer Partners completed their previously announced merger and began trading as Energy Transfer (ET) on October 19. ET stock has been weak

  • One of the largest cannabis companies is going public on the New York Stock Exchange
    Business
    Business Insider

    One of the largest cannabis companies is going public on the New York Stock Exchange

    Aurora Cannabis, one of the largest Canadian marijuana producers, is going public on the New York Stock Exchange. Aurora is joining a select list of Canadian cannabis producers, including Tilray and Cronos, that are able to list on US-based exchanges.

  • Trump’s Tax Push to Help Middle Class Could Help Top Earners Too
    Politics
    Bloomberg

    Trump’s Tax Push to Help Middle Class Could Help Top Earners Too

    It’s still unclear how Trump will propose to reduce the tax burden on middle-class Americans, but one of the most straightforward ways would be to lower rates by 10 percent for single filers making up to $82,500. U.S. income tax rates are graduated and income dollars get taxed in chunks as they move up through the brackets -- which means wealthy Americans would also get to apply the reduced rate on their first dollars of income. “A millionaire gets the same size tax cut,” said Kyle Pomerleau, an economist at the conservative Tax Foundation.

  • 5 Deeply Discounted Value Stocks That Haven't Been This Cheap in at Least a Decade
    Business
    Motley Fool

    5 Deeply Discounted Value Stocks That Haven't Been This Cheap in at Least a Decade

    October has been a wake-up call for investors that the stock market won't go up in a straight line, even if we'd like it to. Sure, Bank of America (NYSE: BAC) has seen its stock catapult higher from its Great Recession lows, but its forward P/E of 9.8 would represent a more-than-decade low for the stock.

  • These stocks may be sacrificed in a cold war with China
    COL
    CNBC Videos

    These stocks may be sacrificed in a cold war with China

    Jim Cramer says the escalation in the United States' trade war with China could end in an outright cold war that debilitates parts of the stock market.

  • Verizon beats Wall Street estimates for profit, phone subscribers
    Business
    Reuters

    Verizon beats Wall Street estimates for profit, phone subscribers

    The largest U.S. wireless carrier knocked up to $750 off the price of some of Apple's new phones, launched in September, as it looks to gain more share in a saturated market. Verizon shares rose slightly to $55.20 in pre-market trading. The company said it added a net 295,000 phone subscribers who pay a monthly bill during the third quarter, beating the estimate of 161,000 provided by research firm FactSet.

  • China Will Open the World's Longest Sea Bridge This Week. A Lot of People Are Unhappy About It
    World
    Fortune

    China Will Open the World's Longest Sea Bridge This Week. A Lot of People Are Unhappy About It

    Later this week, the long-awaited 34-mile sea bridge connecting mainland China to Hong Kong and Macau will finally open. In a ceremony on Tuesday that Chinese president Xi Jinping will reportedly attend, the bridge will officially open. Some critics see the Hong Kong-Zhuhai-Macau Bridge as an attempt by mainland China to tighten its grip on Hong Kong, which is an autonomous region.

  • News
    CNBC

    Here's how much money you should have saved by 50

    Fidelity, the nation's largest retirement-plan provider, recommends having the equivalent of six times your annual salary saved. To get to that number, Fidelity recommends saving 15 percent of your annual income. Make sure to invest these funds instead of leaving them in a traditional low-interest savings account.

  • Shares of downtrodden IBM 'ready to roar higher': Charts
    Business
    CNBC Videos

    Shares of downtrodden IBM 'ready to roar higher': Charts

    Jim Cramer and technician Larry Williams inspect the charts of IBM, which seem to show the beleaguered tech stock on the cusp of a rally.

  • What to Expect from Bristol-Myers Squibb’s Q3 Earnings
    Finance
    Market Realist

    What to Expect from Bristol-Myers Squibb’s Q3 Earnings

    Bristol-Myers Squibb (BMY) is expected to report its third-quarter earnings on October 25. Analysts expect Bristol-Myers Squibb’s revenues to increase 8.87% from $5.25 billion in the third quarter of 2017 to $5.72 billion in the third quarte of 2018. In the last four quarters, Bristol-Myers Squibb’s revenue growth has been 3.93%–10.89%.

  • Kmart employee gives emotional announcement before the store closed permanently
    Business
    AOL.com

    Kmart employee gives emotional announcement before the store closed permanently

    The once-beloved American retailer Sears Holdings filed for bankruptcy earlier this month, and while many consumers were disappointed, thousands of Sears employees were devastated. One heartbroken Kmart store manager in McMurray, Pennsylvania fought back

  • Finance
    InvestorPlace

    What You Need to Know About AT&T Stock Ahead of Earnings

    AT&T (NYSE:T) reports earnings on Wednesday morning – and it looks like an important release. From a multi-year standpoint, AT&T stock has been a huge disappointment. T stock hasn’t moved in about six years.

  • Why Pot Stocks Canopy Growth, Cronos Group, and Tilray Are Cratering Today
    Business
    Motley Fool

    Why Pot Stocks Canopy Growth, Cronos Group, and Tilray Are Cratering Today

    Canadian pot stocks are getting hit hard across the board today. As of 1:21 p.m. EDT, for example, shares of Canopy Growth Corporation (NYSE: CGC) and Cronos Group (NASDAQ: CRON) were both down by 11.2%, whereas Tilray's(NASDAQ: TLRY) stock had fallen by 14.4%. Canopy, Cronos, and Tilray all seem to be succumbing to a so-called "sell the news" event.

  • Finance
    CNBC

    Here's the tax bite on $1.6 billion Mega Millions and $620 million Powerball jackpots

    Strategies can be employed to reduce the amount of your win that is taxed, although they are best explored with the help of an experienced tax advisor. While it's anyone's guess who will end up winning the Mega Millions and Powerball jackpots, there's at least one guaranteed recipient of a chunk of the loot — the IRS. With the Mega Millions jackpot at $1.6 billion and Powerball's top prize at $620 million, that tax bill will be hefty even if the winner employs strategies to reduce their taxable income.

  • Watch out for ‘dead cat bounce’ in stocks because there’s more pain ahead: Morgan Stanley’s Wilson
    News
    MarketWatch

    Watch out for ‘dead cat bounce’ in stocks because there’s more pain ahead: Morgan Stanley’s Wilson

    October is living up to its infamous reputation as a volatile month for stocks with major indexes down sharply and there is likely more pain ahead for investors, according to one prominent Wall Street analyst. The recent rebound “was a dead cat bounce,” said Michael Wilson, an equity strategist at Morgan Stanley, in a report. After eking out gains last week, the S&P 500 (SPX) is trading below the 200 DMA of 2,768 Monday as stocks struggle for direction with third-quarter earnings cycle picking up pace.

  • 4 Things Aurora Cannabis Did Right Before Its NYSE Debut
    Business
    Motley Fool

    4 Things Aurora Cannabis Did Right Before Its NYSE Debut

    Aurora Cannabis (NASDAQOTH: ACBFF) (TSX: ACB) has sought to make it even easier for U.S. investors to buy its shares by arranging to have its shares listed on the New York Stock Exchange. Beginning tomorrow, Oct. 23, Aurora will join the elite group of cannabis companies whose shares trade on major U.S. exchanges. Getting ready for the increased exposure that a NYSE listing brings takes time and effort, and Aurora Cannabis hasn't wasted any time.

  • Bank of America Has Seen the Future: A U.S. Stock Roller Coaster
    Business
    Bloomberg

    Bank of America Has Seen the Future: A U.S. Stock Roller Coaster

    Bank of America Merrill Lynch’s equity and quant team say market signals from the ever-flattening yield curve are clear as day: stock markets are due to begin a new era of elevated price swings. “A flattening yield curve signaled a withdrawal of liquidity and over the last three cycles has preceded rising volatility by a few years,” the team, including Savita Subramanian, wrote in research this week. Bank of America’s call -- echoing others -- comes as investors scramble to judge whether the current turmoil in equity markets represents a blip or fundamental shift in regime.

  • Business
    TheStreet.com

    Verizon Beats Q3 Earnings Estimate, Postpaid Phone Additions Top Forecasts

    shares jumped higher Tuesday after it posted stronger-than-expected third quarter earnings and said it added more telephone users to its network than analysts had anticipated. Verizon said earnings for the three months ending in September came in at $1.22 per share, well ahead of the $1.19 forecast and up 24.5% from the same period last year. "Verizon has posted a third quarter of strong operational and financial performance," said CEO Hans Vestberg.

  • Ford CEO Jim Hackett faces impatient investors ahead of third-quarter earnings
    Business
    CNBC

    Ford CEO Jim Hackett faces impatient investors ahead of third-quarter earnings

    Hackett faces impatient investors and industry analysts who have grown frustrated in recent months by the company's weak performance and his lack of details on the automaker's $11 billion restructuring plans. Hackett embarked on an ambitious restructuring plan and boldly decided earlier this year to phase out all of Ford's sedans, except for the iconic Mustang. Morgan Stanley downgraded Ford last week , saying its earnings and cash flow are under pressure and its dividend is at risk.

  • Why Nektar Therapeutics Crashed 17.2% Today
    Business
    Motley Fool

    Why Nektar Therapeutics Crashed 17.2% Today

    After delivering a disappointing update on NKTR-214 in cancer patients this summer, Nektar Therapeutics' (NASDAQ: NKTR) shares have been struggling. The company didn't report any news today, so a negative report issued by Plainview LLC this month may be to blamed for its 17.2% tumble today. In February, Bristol-Myers Squibb (NYSE: BMY) inked a blockbuster deal to license rights to NKTR-214 following positive data last year for NKTR-214's use alongside Bristol-Myers' Opdivo.

  • Why These 3 Top Marijuana Stocks Slumped Today
    Business
    Motley Fool

    Why These 3 Top Marijuana Stocks Slumped Today

    With earnings season hitting a crescendo this week, investors are looking closely at the specific prospects for certain corners of the market, and that's contributing to disparities among the various major benchmarks followed most often by investors. Amid the crosscurrents, marijuana stocks took particularly hard hits, and New Age Beverages (NASDAQ: NBEV), Tilray (NASDAQ: TLRY), and Canopy Growth (NYSE: CGC) were among the worst performers on the day. All three of these stocks have given back some of their gains following the long-awaited legalization of recreational cannabis in the Canadian market last week. In the month leading up to the Oct. 17 start date for legal cannabis sales, New Age Beverages tripled in value, while Tilray had more than doubled since the end of August, and Canopy Growth had seen more modest gains of between 10% and 20%.

  • Treasury Secretary Steve Mnuchin Quietly Met With the Saudi Crown Prince in Wake of Khashoggi's Killing
    World
    Time

    Treasury Secretary Steve Mnuchin Quietly Met With the Saudi Crown Prince in Wake of Khashoggi's Killing

    As international outrage over the killing of dissident journalist Jamal Khashoggi continues, Treasury Secretary Steve Mnuchin quietly met with Saudi Arabia’s crown prince on Monday, a sign of the Trump administration’s efforts to maintain ties with the embattled Kingdom, the New York Times reports. While Mnuchin canceled his attendance at an investment conference in the Saudi capital this week, he still traveled to Riyadh for a meeting with Crown Prince Mohammed bin Salman, who is widely suspected of playing a role in Khashoggi’s death. Mnuchin has not posted any pictures or statements from the meeting, but Saudi Arabia’s foreign ministry tweeted a photo of Mnuchin and the crown prince, writing that their meeting “stresses the importance of the Saudi-US strategic partnership, where it holds an important role in the future in line with the Kingdom’s #Vision2030.”A Treasury Department spokesman said the two discussed economic ties, counterterrorism, and the investigation into Khashoggi’s death, according to the Times.